Maximum Views Reached

You have reached the maximum number of Guideline views for today. By creating a free account, you can increase your number of complimentary daily views.

To view this Guideline, please log in to your account. If you do not have an account, you can create one for free by clicking the button below.

Thromboprophylaxis in Patients with COVID-19

Publication Date: February 10, 2022

Last Updated: March 14, 2022

Summary of Recommendations

In acutely ill hospitalized patients with COVID-19 who have low risk of bleeding, with consideration for the remarks below, we suggest therapeutic dose heparin (UFH or LMWH) over current standard dose anticoagulant thromboprophylaxis (C, U)

Thromboprophylaxis in Patients with COVID-19

Summary of Recommendations

Overview

Title

Authoring Organization